Abstract
Background
Although cognitive and behavioral factors significantly impact dermatological outcomes, psychobehavioral interventions remain inaccessible and underused.
Objective
To develop and test a psychobehavioral intervention (MindMySkin) delivered via a mobile application.
Methods
Needs assessment, evidence-based module development, and formative user-centered evaluation were conducted in participants with eczema, psoriasis, or chronic urticaria. The developed prototype modules were further iteratively refined following additional qualitative and quantitative feedback.
Results
27 participants contributed to 24 1:1 interviews and 231 responses between June 2023 and November 2024. Modules were highly rated (median score 4 or 5/5) for utility, interest, understandability, and recommendation for inclusion, underscoring strong acceptability. Participants valued the informative content and conversational tone but highlighted skepticism toward reflection exercises and oversimplification of patient difficulties. Design challenges include balancing time demanding but effective modules with shorter more appealing content. The final intervention comprised 74 modules addressing illness coherence, symptom management, functional impairment, emotional impairment, and the patient–physician relationship.
Limitations
No participant reviewed the full program and modules were assigned, limiting insights on voluntary adherence.
Conclusion
This study establishes the unmet need for psychotherapeutic support and demonstrates the acceptability, appropriateness, and usability of a self-administered psychobehavioral intervention in improving dermatological care.
Key words: behavioral, chronic skin disease, complex interventions, dermatology, digital, eczema, feasibility study, health services research, implementation, mental health, mhealth, patient outcomes, patient-centered care, psoriasis, psychodermatology, psychological, psychotherapeutics, urticaria, user acceptability
Capsule Summary.
-
•
Psychological interventions are important yet underused in managing chronic inflammatory skin diseases.
-
•
This study develops and demonstrates the feasibility of MindMySkin, a digital psychotherapeutic intervention suitable for use alongside clinical care.
Introduction
Skin conditions are among the leading causes of disability globally,1, 2, 3 with quality of life (QoL) impairment expected to further increase.4,5 Unlike other chronic diseases, in many skin conditions, the correlation between QoL impairment and objective disease severity is weak.6,7 Instead, QoL impairment has a stronger correlation with psycho-behavioral factors such as anxiety, depression, resilience, coping, and body image.7, 8, 9
Studies have demonstrated the effectiveness of psychological interventions, including habit reversal training, relaxation techniques, and cognitive behavioral therapies, in decreasing the disease burden of inflammatory skin diseases.10, 11, 12, 13, 14, 15 Despite the evidence, such interventions are not routinely prescribed, partially because dermatologists lack the time and training to deliver them and instead prioritize biomedical therapeutics.8,15,16
Digital self-administered interventions, such as mental health applications, have emerged to meet this gap by offering a scalable solution that functions independently of active clinician intervention.17,18 When well constructed, these can extend the therapeutic reach of dermatologists, psychiatrists, and psychologists beyond traditional clinical settings, allowing specialists to focus on patients with more complex needs. However, as little as 3% to 4% of available applications are supported by scientific evidence or even affiliated with healthcare experts.19 This underscores a very clear need for the structured development and rigorous evaluation of such digital interventions.
In response, we developed MindMySkin, a digital self-administered psycho-behavioral intervention deployed via a mobile application. The purpose of this framework-guided intervention is to target unhealthy psychological, behavioral, cognitive, and social habits to improve self-efficacy, resilience, and coping skills, thereby reducing the symptom burden and impact of skin disease on QoL (Fig 1).
Fig 1.
Graphical depiction of MindMySkin’s purpose.
Methods
We used the UK Medical Research Council Framework for Developing Complex Interventions20 to guide our development process and adapted it with specific modifications to accommodate nuances of digital intervention development. The multidisciplinary team consisted of dermatologists (V.L., N.C., and Y.P.M.), psychodermatologists (E.C. and J.D.), a clinical psychologist (K.H.), a cognitive behavioural therapy (CBT) trained counselor (C.W.I.), a psychiatrist (C.H.), behavioral economist (P.P.), industry partner (Intellect Inc), and patient representatives (J.C., A.C., and R.L.). Patient representatives were involved at the start of development and played a pivotal role in ensuring that the content aligned with patients’ interests and perspectives and providing comments about the study design and questionnaires. The National Healthcare Group Domain Specific Review Board approved this study (2022/00751).
The development of the intervention included the following stages.
Needs assessment
Relevant patient factors were identified from our previous studies.7,8 They included realistic self-assessment of disease severity, knowledge about the disease, dealing with disease chronicity, tolerating distress, healthy disease representations, social comparisons,21, 22, 23 destructive self-talk, scratching, itch, self-control, self-efficacy, concerns about topical steroids and medication adherence,24, 25, 26 maintaining normal social life, and effective communication with the physician.27,28
In addition, we conducted semi-structured qualitative interviews with 24 participants (between June 2023 and January 2024) to gather feedback on their challenges, needs, and desired features of a mobile application. Inclusion criteria included individuals aged 16 years and older diagnosed with eczema, psoriasis, or urticaria of a minimum 3-month duration. Participants were recruited via convenience sampling from outpatient clinics or word of mouth. 1:1 interviews were conducted in person or over Zoom, and transcripts were analyzed using inductive thematic analysis, where codes and themes were allowed to develop with progressive and iterative analysis of data.
Co-design and crafting of the content
We began the process with a literature review in December 2022 on existing psychotherapeutic interventions for dermatological disease, such as cognitive-behavioral therapy and habit reversal training, which have been shown to be effective in the dermatological population.11, 12, 13,17 Strategies addressing related conditions such as chronic pain, fatigue, and health anxiety were also reviewed.29, 30, 31, 32, 33
We then used the Theory of Change model34,35 as a guiding framework to systematically map the logical pathway linking patients’ needs, psychotherapeutic interventions, intermediate outcomes, and long-term outcomes. Existing psychotherapeutic strategies such as cognitive behavior therapy, habit reversal training, and guided imagery14,36,37 were adapted to address each identified need, such as itch, visible skin lesions, disease chronicity, and cyclicity.38 Where existing strategies were lacking, we developed new ones using the COM-B model and Behavioral Change Wheel39 such as distraction, social comparison and self-talk to manage needs such as low self-efficacy, emotional distress, and activity limitation.
Content was formatted into 4 major categories: (1) Learning paths for delivery of core concepts, (2) Guided journals for self-reflection and symptom tracking, (3) Rescue sessions for quick relief during physical or emotional distress, and (4) Therapeutic audio tracks for mindfulness, relaxation, and grounding. The intervention also included self-assessment tools such as quizzes and questionnaires to monitor disease severity, emotional well-being, and coping patterns.
This started in March 2023 and was followed by multiple rounds of iteration, testing, refinement (c.f. point 3), and was finalized in January 2025. The team leveraged its combined strengths and experience in developing educational content, designing behavioral health interventions, and promoting the adoption of digital health tools.25,40, 41, 42, 43, 44, 45, 46, 47 Simultaneously, our application development collaborator brought industry expertise in optimizing user engagement and mobile health platforms.18,48,49 These aimed to optimize the intervention for digital delivery to ensure accessibility, engagement, and ease of use while maintaining its core therapeutic principles.
Formative user-centered evaluation
The developed content was tested with participants, with the inclusion criteria and recruitment strategy remaining identical to those outlined before, and allowing for the possibility of overlapping participants (modules could be tested as part of the qualitative interviews and each participant could test more than 1 module).
Participants were individually presented with Word or PDF copies of the content and asked to provide structured and open-ended feedback for each module. Structured quantitative feedback was collected using a 5-point Likert scale ranging from 1 (strongly disagree) to 5 (strongly agree) on constructs including the module’s level of interest, ease of understanding, usefulness, time required for completion, and recommendation for including that module in the application. Open-ended qualitative feedback was also gathered.
Each module was tested by at least 3 participants. Modules were often retested iteratively following edits prompted by negative feedback or significant suggestions from participants. Modules that consistently scored low (with an average rating of 3/5 or lower) were dropped from the intervention.
Results/Findings
Fig 2 presents a summary of the 3 stages, which are further elaborated below.
Fig 2.
Key methods and results of the study’s 3 stages.
Identification of patients’ needs
Five key areas of need were identified from 24 qualitative interviews, namely, illness coherence, symptom management, functional impairment, emotional impairment, and the patient–healthcare provider interaction. Within these, subthemes include difficulty understanding and accepting disease chronicity and unexplainable flares, challenges managing itch and scratching, limitations with hobbies and daily activities, negative emotions of helplessness and self-pity, rushed consultation with physicians, and inability to promptly obtain medical advice during flares (Supplementary Table I, available via Mendeley at https://data.mendeley.com/datasets/b5vwjypnt2/1).
Development of the intervention
Informational content
Table I presents a Theory of Change Model35 which details the interventional content, showing how the proposed solutions attempt to solve the identified needs and the intended outcomes and measures for evaluation. Naming and grouping of the behavior change techniques follows the Behavior Change Technique Taxonomy by Michie et al.50
Table I.
Relationship between identified need, proposed solution, intended outcome, and outcome measure (Theory of Change Model)
| Clinical need | Interventional content proposed | Mechanism of action∗ | Proposed outcome measure |
|---|---|---|---|
| Illness coherence | |||
| Information gaps leading to inability to understand and accept condition Lack of understanding of cause, chronicity, natural course of condition, and therapy |
Learning paths Improving understanding and management of eczema, psoriasis, and chronic urticaria - Comprehensive educational resource covering disease pathogenesis, triggers, idea of chronicity, and misconception. A guide to topical steroids - Appropriate and safe usage of topical steroids and nonsteroidal alternatives. |
Shaping knowledge | Questions assessing content knowledge (only in-application) IPQ-R Acceptance of chronic health conditions scale Adherence scale (validation in progress) |
| Inaccurate assessment of severity Perceiving higher severity than clinically determined. |
Learning paths 1. Evaluating the severity of your skin condition - Teach disease rating for better self-assessment including estimating BSA affected - Illustrate disease severity through photographs |
Exposure to entire spectrum of disease severity, improving nature of social comparison | Difference between patient and physicians’ rating of global disease severity. Confidence of self-assessment in disease severity (only in-application) |
| Symptom management | |||
| Managing itch Inability to control scratching Distressing itch crisis Impaired sleep from itch |
Learning paths 1. Itch neuroscience education 2. How to reduce itching and scratching Guided journal 1. Characterizing your scratching Rescue session 1. Overcoming intense itching attacks Mindfulness sessions - Guided audio including progressive muscle relaxation, hypnotic suggestions, and guided imagery |
Shaping knowledge, goals and planning, feedback and monitoring, natural consequences repetition and substitution, and regulation antecedents | Itch, sleep, and pain NRS 5-D itch scale (only in-application) PROMIS itch (only in-application) DLQI (QoL impairment) WPAI Physician-assessed scratching scale |
| Challenges with a cyclical disease Suboptimal and reactive management |
Guided journal 1. Written action plan 2. Weekly check in 3. Trigger journaling |
Shaping knowledge, repetition, and substitution | IPQ-R Brief Resilience Scale DLQI |
| Functional impairment | |||
| Activity limitations Difficulties with function and sleep |
Learning paths 1. Values training and gratitude list 2. Tips for adapting to a life with skin disease 3. Time to work out our problems |
Associations repetition and substitution Antecedents Identity |
WPAI DLQI Adherence scale |
| Interpersonal and social interactions | Learning paths 1. Dealing with unwanted comments 2. Improving appearances |
Valued self-identity | DLQI, PROMIS Self-Efficacy for Managing Emotions 4a, depression 8b |
| Emotional impairment | |||
| Negative thoughts Sense of helplessness Negative cycle of rumination, self-pity |
Learning paths 1. Creating space from negative thoughts - Cognitive defusion techniques 2. Trading negative thoughts for balanced insights - Cognitive restructuring |
Shaping knowledge, comparison of behavior, associations, and regulation | IPQ-R BRS PROMIS Depression 8b and Anxiety 7a |
| Negative emotions Feeling ‘upset’ and ‘depressed’ Believing happiness depends on curing their skin condition |
Rescue sessions 1. Tackling the worry 2. STOPping our negative emotions Guided journal 1. Emotion and gratitude journaling 2. Self-care and gratitude Mindfulness audios 1. Sitting with discomfort |
Nonspecific incentive, framing/reframing, valued self-identity, and self-belief | IPQ-R WHO-5 PROMIS Self-Efficacy for Managing Emotions 4a, Depression 8b, and Anxiety 7a |
| Low self-esteem and body image Negative social comparisons to others |
Learning paths 1. Befriending yourself 2. The link between skin conditions and body image 3. What (I think) people think about me 4. Dealing with unwanted comments 5. Improving appearances 6. Embracing body dissatisfaction & living well Mindfulness audios 1. Noting - Letting go of comparisons |
Framing/reframing, valued self-identity, and self-belief | WBIS DLQI WHO-5 DSC |
| The patient–healthcare provider interaction | |||
| Insufficient time and rushed consult | Learning paths 1. How to achieve the most from your consult |
Shaping knowledge Improved communication |
Partners in health (only in-application) DLQI |
| Assumptions† Patients will recognize the value of the content and engage with the application Users are able to comprehend the English language and can navigate a health application. | |||
| External factors‡: Competition from other mobile applications and mental health tools, cyber-security threats or data breaches, possible vendor withdrawal | |||
IPQ-R encompasses domains including illness coherence, emotional representation, consequences, cyclicity, personal, and treatment control domain.
5-D, 5-dimensional; BRS, Brief Resilience Scale; BSA, body surface area; DLQI, Dermatology Quality Life Index; DSC, Dermatology Social Comparison; IPQ-R, Revised Illness Perception Questionnaire; NRS, Numerical Rating Scale; PROMIS, Patient-Reported Outcomes Measurement Information System; QoL, quality of life; WBIS, Weight Bias Internalization Scale; WHO-5, World Health Organization-Five Well-Being Index; WPAI, Work Productivity and Activity Impairment Questionnaire.
Terminology follows the Behavior Change Technique Taxonomy by Michie et al (2013).
Assumptions refer to underlying beliefs considered necessary for the intervention to be successful.
External factors are factors beyond control that can facilitate or impair success.
The following approach was used to encompass an integrated and comprehensive management approach encompassing both biological and psychosocial dimensions.
-
1.
Disseminating knowledge via text, illustrations, and audio recordings within structured modular learning paths.
-
2.
Employing pictorial storylines to enhance relatability and peer learning.
-
3.
Theoretical education strengthened with practical walk-through exercises on psychological tools like cognitive behavioral therapy and habit reversal training.
-
4.
Using questionnaires with score interpretation and reference banding, encouraging awareness and self-insight.
-
5.
Offering guided journaling to facilitate recollection, reflection, and monitoring.
-
6.
Providing rescue sessions with distraction or mindfulness techniques to ameliorate distressing symptoms like itch.
Content delivery and user experience
As short, easily digestible and enjoyable content are important elements for today’s users of digital applications;51,52 the content strategy included breaking down information into brief concise pieces. Relatable quotes and the use of nonconfrontational language were incorporated to improve engagement. We avoided oversimplifying explanations with metaphors or lay terms, choosing to retain the scientific names of medications and treatments for reliability while maintaining a conversational and professional tone. This decision promotes transparency and empowers users by fostering a better understanding and management of their treatment plans.
While many applications focus on gamification for engagement, we wanted to avoid trivializing content or creating additional distraction and cognitive load.53,54 Instead, we focused on creating an interface that minimizes clicks and provides seamless navigation between modules to enhance engagement.
Platform and technical development
MindMySkin was hosted onto Intellect, an existing mobile application developed by Singapore-based Intellect Inc.55 The Health Insurance Portability and Accountability Act (HIPAA)-compliant application offers mental health strategies targeted at the general population with proven efficacy in prior randomized trials on stress reduction,48 worry,18 and body image.49 Existing modules of the application were excluded from present study; however, we leveraged Intellect’s expertise in content development and existing infrastructure for cost-effective and synergistic integration.
The application employs a robust technical stack, including Amazon Web Services for secure cloud computing, React Native for responsive cross-platform functionality, and MySQL for efficient data management. Intellect is ISO 27001 certified, compliant with Singapore's Personal Data Protection Act and employs Zero-Knowledge Encryption, encrypting data at the device level for user-only access.
Formative user-centered evaluation
A total of 231 responses were collected from 27 participants between June 2023 and November 2024. Median feedback scores ranged from 4 to 5 on a Likert scale (5 being the highest), suggesting high ratings for the usefulness, clarity, and engagement of the modules (Table II). Time commitment was also deemed reasonable and there was strong support for including the modules in the intervention (median score of 5; interquartile range: 4-5).
Table II.
Summary of structured feedback from formative evaluation (n = 231)
| Domains | Median score (interquartile range) |
|---|---|
| Utility | 4 (4-5) |
| Interest | 4 (4-5) |
| Time requirement∗ | 5 (4-5) |
| Understandability | 5 (4-5) |
| Coherence/sensibility | 5 (4-5) |
| Insensitivity | Yes: 7.36%; No: 92.64% |
| Recommendation for inclusion | 5 (4-5) |
Responses were graded on a 5-point Likert scale ranging 1 (strongly disagree) to 5 (strongly agree).
Two different statements were used for this domain: “The length of the meditation session was reasonable” for mindfulness sessions (median = 4 [4-5]), and “The time taken to complete the content/tool was reasonable” for all other modules (median = 5 [4-5]). Responses were combined.
Common themes from the qualitative feedback included appreciation of the ‘informative’ content that were ‘easily digestible’ and ‘short and sweet’ (Table III). Longer modules that took 10-15 mins were viewed by some as too lengthy. At the same time, we recognized the need to cultivate increased attention and for sufficient time commitment to facilitate meaningful learning. Thus, we retained these modules and exercises while reducing the quantity of text as far as possible without compromising learning.
Table III.
Summary of open-ended qualitative feedback from formative evaluation
| Theme | Exemplar quote |
|---|---|
| Likes | |
| Knowledge dissemination in understandable format | “Bite-sized nuggets of information… easy to digest.” “Would not have considered behavioral and psychological aspects to my condition if not for these questions. Good insight to how I feel.” “Adds to knowledge - learned something new, more than what doctors will tell patients.” |
| Practical and relevant solutions | “Gives practical solutions and alternative methods to reduce scratching.” |
| Enhancing self-awareness, resilience, and emotional well-being | “Helps a patient to reflect on our inner emotions and allows us to be sure of what we are feeling.” “Makes the user feel like there’s a friend to talk to and there’s some guidance in processing through the negative thought.” “Helps you to see how to coexist with your skin condition”. |
| Dislikes | |
| Too much reflection, too little actionable solutions | “What is the point of grading yourself on a scale if nothing comes out of it in the app? Too much self-reflection.” “Doesn't provide methods to break away from the thought patterns.” |
| Privacy and data security concerns | “Patients need to know that the photos submitted will be kept confidential…not sure who will be seeing it or what it could be used for.” |
| Lack of visual aids in patient education | “More visuals for understanding things related to your own body.” “The instructions could be better followed with a cartoon diagram. Or a gif of someone doing it.” |
| Lack of human interaction and limited responsiveness to user needs | “Those looking for help, there is no follow through. Eg who to talk to.” “A counseling hotline might be better than facing a screen… Won’t feel heard in an app.” |
| Areas of confusion or insensitivity | |
| Challenging to understand the mind-skin connection | “Hard to visualize how the improved mind actually helps with the skin.” |
| Excessive text and overuse of medical jargon | “A lot more illustrations/pictures should be included. Reading a wall of text is very boring.” “Some of the text seems very doctor-centric.” |
| Unrelatable, toxic positivity, and oversimplification of complex issues | “The comic strip was pretty insensitive…as if to illustrate that as long as they have body positive imagery, everything would be fine... Having such a simplified cartoon of 2 juxtapositions won't be relatable to anyone, because more often than not, eczema embodies both states at once.” |
| Disempowering advice, teaching tolerance over boundary setting | “The module teaches responding politely to unwanted comments...in a way that feels like patients owe kindness to people…make it so the content helps the patient to navigate uncomfortable situations rather than teaching them how to appear more palatable to the public.” |
| Other comments | |
| Time consuming | “Feels long, may not have patience to finish it.” |
| Impersonal advice | “I do not feel that it helps me because it asks me to focus on my own issues without asking for the help that I need.” |
| Desire for real-time human guidance and interaction | “I would suggest having someone to guide people through this app…without any human guidance, can be a bit confusing.” “Vocalizing my thoughts would flag to medical caregivers that I have an issue and also allow a better rationalization of them.” |
| Desire for peer support and community engagement | “[Meditation] has its limitations as there is no subsequent step with an active approach…. A community approach could be done…might benefit better from sharing and learning from other patients who walked the path, for emotions, ailments, and strategies.” “The negative emotions from patients should be channeled into something positive to help others, either to share their pain or to inspire them in the journey of healing.” |
| Desire for engaging user interface and more visual aids | “I think that the interface really matters a lot…having a simple and intuitive interface.” “Visuals could be added to keep the users attention.” |
Some participants expressed preference for practical and actionable solutions over reflective exercises for insight building and wanted to see a clearer rationale for the psychologically focused modules. In response, we simultaneously reduced the volume of reflective questions asked as part of the intervention and provided data-backed explanations underscoring the relevance of building self-awareness and emotional coping strategies.
Areas highlighted as being potentially insensitive were carefully reviewed. One area related to the oversimplification of the challenges patients faced. For example, some participants felt that being asked to relax, reframe their thought, or focus on beneficial solutions were pressuring them into positivity and was not something they could control. Changes were made to emphasize patient difficulties and to acknowledge progress as a continuum rather than a dichotomy. For example, goals were framed as achieving balanced rather than purely positive thoughts, and mindfulness techniques were designed to foster acceptance without judgment rather than the pursuit of wellbeing per se.
A conversational tone such as “Hi, it’s me, Dr…” was well received for both text and audio files. Participants expressed acceptance and in some cases, a preference for recordings by local study team members over professional voice actors, even if the narration was less polished. Textual information was copyedited to balance engagement (eg, use of emojis, simple and catching language) with professionalism and scientific rigor.
In the process of testing, modules were extensively edited and reorganized. Various new modules were added while 1 module, a guided food journal, was removed as most participants found this overly tedious and of little value (Table IV). The final intervention comprised 74 modules, each taking an average of 7.2 (standard deviation: 4.0) minutes to complete. These were organized into the 5 key needs earlier identified: illness coherence, symptom management, functional impairment, emotional impairment, and the patient–physician relationship.
Table IV.
Examples of changes made from formative evaluation
| Area of improvement | Changes made |
|---|---|
| Poor engagement | Shortened and simplified text, minimized jargon, adopted a conversational tone, added emojis, and additional illustrations. Removed module on “guided food journal” and streamlined tracking of triggers which was deemed tedious. |
| Preference for more practical solutions and less reflection | Reduced reflective questions and added clear explanations on how psychological strategies benefit skin health. Interspersed greater practical tips and concrete recommendations among reflective exercises. |
| Insensitive advice (toxic positivity and disempowering) | Refined content to be more nuanced and reflective of patient-lived experiences, avoided simplistic advice, acknowledged individual differences in handling challenges, and offered options for solutions. |
| Customizable user experience | Modules made optional and accessible at any time. |
| Peer support and community | Added quotes on patient-lived experiences and links to local skin support groups. |
Discussion
Symptom burden comprises the interplay between objective disease and the cognitive and behavioral responses of the patient56, 57, 58 and both need to be addressed. The development of MindMySkin represents a theoretically grounded and evidence-informed attempt to rigorously develop and deliver structured psychodermatological care. Early involvement of stakeholders such as patients and commercial partners optimizes it for sustainable adoption while plans for subsequent testing in a randomized controlled trial59 will provide efficacy data.
Lessons that can be drawn for developers of patient education include the need to balance differing objectives of what the clinician wants to deliver, what the patient actually needs for improvement, and what the patient finds enjoyable and meaningful. For example, patients in our study tended to prefer actionable and tangible solutions for specific symptoms, while the clinical team wanted to also promote introspective elements with a focus on coping and self-management. Explaining the rationale of learning different skills (mindfulness and balanced thinking) was understood to be important but challenging to convey in written words.
Another challenge was optimizing and personalizing the content for each user. The same feature was simultaneously enjoyed by some and disliked by others. Some valued the focus on emotional well-being, while others considered those modules “too soft”. Repetition, which is crucial for building a skill, was perceived as some by redundant and excessive. To accommodate differing preferences, we provided module suggestions throughout the intervention to guide participants to suitable modules while keeping all modules optional and freely accessible. Future use of detailed algorithms and artificial intelligence could enable greater personalization.
Limitations include use of convenience sampling, which skewed the sample toward younger participants with higher literacy, although this arguably aligns with the intervention’s target population. Additionally, each participant appraised only selected modules over a relatively short period (module-level feasibility), which reduced participant burden but meant that no participant had reviewed the entire set of modules. Additionally, the long-term adherence and voluntary use of the application without pressure or reminders from the study team remain to be seen. Finally, the intervention currently has limited integration with clinical care pathways and electronic health records which could improve usability and utility.
Conflicts of interest
Author E.C. has received grant funding from Pfizer for an investigator-initiated trial on atopic dermatitis, that is unrelated to present work. She is also associate/assistant editor for Journal of the American Acaedemy of Dermatology (JAAD), JAAD International, and International journal of Dermatology. Author P.P. holds editorial positions for the International Journal for Quality in Health Care, Medicine, and Journal of Technology Transfer. Author N.S.C. has received fees for participation in advisory boards from AbbVie, Johnson & Johnson, Sanofi, Pfizer, DKSH, L'Oreal and Novartis, investigator fees for clinical trials from AbbVie, Novartis, Amgen, Sanofi, and Boehringher Ingelheim and speaker honoraria from Galderma, Johnson & Johnson, LEO, Pfizer, Sanofi, and Lion Corporation. Author O.S. is an employee of Intellect Pte Ltd, a mental healthcare company based in Singapore, and hold equity in the company. He contributed valuable industry insights for the content. However, he had no involvement in the study design, collection, analysis of data, patient interactions, the determination of the final intervention content, or decision to publish. He participated in writing and reviewing of the manuscript. Intellect Pte Ltd does not hold any copyright or ownership rights to the MindMySkin application. All authors have played a role in the development of MindMySkin. There are no other conflicts of interest relevant to this study to declare.
Acknowledgments
The team would like to thank our patient representative Ms Joyce Choo, Mr Reuben Loo, and Mr Alfred Choi for their continual engagement throughout the development of MindMySkin. Their involvement has included co-designing learning modules with detailed feedback and suggestion, testing the application interface and usability and reviewing study materials such as the protocol, participant questionnaires, and overall trial design to ensure patient-centeredness and clarity. They also provided iterative feedback on manuscript drafts, helping us communicate findings in a manner that is accessible to both clinicians and patients. Their sustained insights have been invaluable in shaping a user-friendly and patient-focused intervention.
Footnotes
Authors Chua and Long are Co-first author.
Authors Hsu and Choi are Co-last authors.
Choi, Ellie (2025), “Digital psychotherapeutic interventions to reduce dermatological symptom burden: The development and testing of MindMySkin”, Mendeley Data, V1, https://doi.org/10.17632/b5vwjypnt2.1.
Funding sources: This study was funded by NUHS Clinician Scientist Programme v2.0 and National Medical Research Council Clinician Scientist Individual Research Grant New Investigator award, awarded to the PI E.C. The funder had no role in the study design, collection, analysis, interpretation of data, writing of paper, or decision to publish.
IRB approval status: Approved by NHG DSRB (2022/00751).
References
- 1.Na C.H., Chung J., Simpson E.L. Quality of life and disease impact of atopic dermatitis and psoriasis on children and their families. Children. 2019;6(12):133. doi: 10.3390/children6120133. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Sanclemente G., Burgos C., Nova J., et al. Asociación Colombiana de Dermatología y Cirugía Dermatológica Asocolderma The impact of skin diseases on quality of life: a multicenter study. Actas Dermosifiliogr. 2017;108(3):244–252. doi: 10.1016/j.ad.2016.11.008. [DOI] [PubMed] [Google Scholar]
- 3.Choi E., Cook A.R., Chandran N.S. Hidradenitis suppurativa: an Asian perspective from a Singaporean institute. Skin Appendage Disord. 2018;4(4):281–285. doi: 10.1159/000481836. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Hay R.J., Johns N.E., Williams H.C., et al. The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions. J Invest Dermatol. 2014;134(6):1527–1534. doi: 10.1038/jid.2013.446. [DOI] [PubMed] [Google Scholar]
- 5.Xiong J., Xue T., Tong M., Xu L., Bai B. Dynamic trend analysis of global psoriasis burden from 1990 to 2021: a study of gender, age, and regional differences based on GBD 2021 data. Front Public Health. 2025;13 doi: 10.3389/fpubh.2025.1518681. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Long V., Lau X.M.N., Ng C.X., Phan P., Choi C.E.E. Discordance in perception of disease severity between patient and physicians. Eur J Intern Med. 2023;109:138–140. doi: 10.1016/j.ejim.2022.11.010. [DOI] [PubMed] [Google Scholar]
- 7.Long V., Chen Z., Du R., et al. Understanding discordant perceptions of disease severity between physicians and patients with eczema and psoriasis using structural equation modeling. JAMA Dermatol. 2023;159(8):811–819. doi: 10.1001/jamadermatol.2023.2008. [cited 2023 July 12]; Available from. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Choi C.E.E., Yee M.Y.F., Tan L.Y.L., Phan P. A qualitative study of dermatology patients and providers to understand discordant perceptions of symptom burden and disease severity. J Dermatol Treat. 2022;33(4):2344–2351. doi: 10.1080/09546634.2021.1961996. [DOI] [PubMed] [Google Scholar]
- 9.Barbieri J.S., MacDonald K. Exploring discordance between patients and clinicians—understanding perceived disease severity. JAMA Dermatol. 2023;159(8):807–809. doi: 10.1001/jamadermatol.2023.2007. [cited 2023 July 21]; Available from. [DOI] [PubMed] [Google Scholar]
- 10.Fortune D.G., Richards H.L., Kirby B., Bowcock S., Main C.J., Griffiths C.E. A cognitive-behavioural symptom management programme as an adjunct in psoriasis therapy. Br J Dermatol. 2002;146(3):458–465. doi: 10.1046/j.1365-2133.2002.04622.x. [DOI] [PubMed] [Google Scholar]
- 11.Hedman-Lagerlöf E., Fust J., Axelsson E., et al. Internet-delivered cognitive behavior therapy for atopic dermatitis: a randomized clinical trial. JAMA Dermatol. 2021;157(7):796–804. doi: 10.1001/jamadermatol.2021.1450. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Chida Y., Steptoe A., Hirakawa N., Sudo N., Kubo C. The effects of psychological intervention on atopic dermatitis. A systematic review and meta-analysis. Int Arch Allergy Immunol. 2007;144(1):1–9. doi: 10.1159/000101940. [DOI] [PubMed] [Google Scholar]
- 13.Hua T., Kim L.S., Yousaf M., et al. Psychological interventions are more effective than educational interventions at improving atopic dermatitis severity: a systematic review. Dermatitis. 2023;34(4):301–307. doi: 10.1097/DER.0000000000000868. [DOI] [PubMed] [Google Scholar]
- 14.Revankar R.R., Revankar N.R., Balogh E.A., Patel H.A., Kaplan S.G., Feldman S.R. Cognitive behavior therapy as dermatological treatment: a narrative review. Int J Womens Dermatol. 2022;8(4) doi: 10.1097/JW9.0000000000000068. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Hewitt R.M., Ploszajski M., Purcell C., et al. A mixed methods systematic review of digital interventions to support the psychological health and well-being of people living with dermatological conditions. Front Med. 2022;9 doi: 10.3389/fmed.2022.1024879. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Rameez S., Nasir A. Barriers to mental health treatment in primary care practice in low- and middle-income countries in a post-covid era: a systematic review. J Fam Med Prim Care. 2023;12(8):1485. doi: 10.4103/jfmpc.jfmpc_391_22. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Kern D., Ljótsson B., Lönndahl L., et al. Self-guided vs clinician-guided online cognitive behavioral therapy for atopic dermatitis: a randomized clinical trial. JAMA Dermatol. 2024;161(2):183–190. doi: 10.1001/jamadermatol.2024.5044. [cited 2025 Jan 28]; Available from. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Kosasih F.R., Yee V.T.S., Toh S.H.Y., Sündermann O. Efficacy of Intellect's self-guided anxiety and worry mobile health programme: a randomized controlled trial with an active control and a 2-week follow-up. PLOS Digit Health. 2023;2(5) doi: 10.1371/journal.pdig.0000095. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Leong Q.Y., Sridhar S., Blasiak A., et al. Characteristics of Mobile health platforms for depression and anxiety: content analysis through a systematic review of the literature and systematic search of two app stores. J Med Internet Res. 2022;24(2) doi: 10.2196/27388. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Skivington K., Matthews L., Simpson S.A., et al. A new framework for developing and evaluating complex interventions: update of medical research council guidance. BMJ. 2021;374 doi: 10.1136/bmj.n2061. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Festinger L. A theory of social comparison processes. Hum Relat. 1954;7(2):117–140. [Google Scholar]
- 22.Gerber J.P., Wheeler L., Suls J. A social comparison theory meta-analysis 60+ years on. Psychol Bull. 2018;144(2):177–197. doi: 10.1037/bul0000127. [DOI] [PubMed] [Google Scholar]
- 23.Choi E., Du R., Yew Y.W., et al. Development and validation of the dermatology social comparison (DSC) scale. Int J Dermatol. 2024;63(10):1433–1438. doi: 10.1111/ijd.17146. [DOI] [PubMed] [Google Scholar]
- 24.Choi E., Chandran N.S., Tan C. Corticosteroid phobia: a questionnaire study using TOPICOP score. Singapore Med J. 2020;61(3):149–153. doi: 10.11622/smedj.2019110. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Choi E., Tan K.W., Tang F., Tan C., Chandran N.S. Efficacy of targeted education in reducing topical steroid phobia, A randomised clinical trial. J Am Acad Dermatol. 2020;83(6):1681–1687. doi: 10.1016/j.jaad.2020.02.079. [DOI] [PubMed] [Google Scholar]
- 26.Tan S., Phan P., Law J.Y., Choi E., Chandran N.S. Qualitative analysis of topical corticosteroid concerns, topical steroid addiction and withdrawal in dermatological patients. BMJ Open. 2022;12(3) doi: 10.1136/bmjopen-2022-060867. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Sim W., Michelle T.H.S.C., Lim N.Q.B.I., et al. Why do pressure injuries still occur? A multicenter qualitative study of nurses and caregivers. JAAD Int. 2024;17:29–36. doi: 10.1016/j.jdin.2024.05.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Choi E., Patwardhan K.R., Long V., et al. Patient-physician concordance in age, sex, and race is not associated with increased trust, satisfaction, empathy, or physician's perception of a difficult patient in Singapore. J Am Acad Dermatol. 2024;90(2):434–436. doi: 10.1016/j.jaad.2023.10.022. [DOI] [PubMed] [Google Scholar]
- 29.Linton S.J., Boersma K., Vangronsveld K., Fruzzetti A. Painfully reassuring? The effects of validation on emotions and adherence in a pain test. Eur J Pain Lond Engl. 2012;16(4):592–599. doi: 10.1016/j.ejpain.2011.07.011. [DOI] [PubMed] [Google Scholar]
- 30.Langlois P., Perrochon A., David R., et al. Hypnosis to manage musculoskeletal and neuropathic chronic pain: a systematic review and meta-analysis. Neurosci Biobehav Rev. 2022;135 doi: 10.1016/j.neubiorev.2022.104591. [DOI] [PubMed] [Google Scholar]
- 31.Dibley L., Khoshaba B., Artom M., et al. members of the IBD-BOOST PPI team Patient strategies for managing the vicious cycle of fatigue, pain and urgency in inflammatory bowel disease: impact, planning and support. Dig Dis Sci. 2021;66(10):3330–3342. doi: 10.1007/s10620-020-06698-1. [DOI] [PubMed] [Google Scholar]
- 32.Newland P., Bettencourt B.A. Effectiveness of mindfulness-based art therapy for symptoms of anxiety, depression, and fatigue: a systematic review and meta-analysis. Complement Ther Clin Pract. 2020;41 doi: 10.1016/j.ctcp.2020.101246. [DOI] [PubMed] [Google Scholar]
- 33.Kaplun A., Alperovitch-Najenson D., Kalichman L. Effect of guided imagery on pain and health-related quality of life in musculoskeletal medicine: a comprehensive narrative review. Curr Pain Headache Rep. 2021;25(12):76. doi: 10.1007/s11916-021-00991-y. [DOI] [PubMed] [Google Scholar]
- 34.Breuer E., Lee L., De Silva M., Lund C. Using theory of change to design and evaluate public health interventions: a systematic review. Implement Sci IS. 2016;11:63. doi: 10.1186/s13012-016-0422-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.De Silva M.J., Breuer E., Lee L., et al. Theory of change: a theory-driven approach to enhance the medical research Council's framework for complex interventions. Trials. 2014;15(1):267. doi: 10.1186/1745-6215-15-267. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Van De Ven A.H., Johnson P.E. Knowledge for theory and practice. Acad Manage Rev. 2006;31(4):802–821. [Google Scholar]
- 37.David Creswell J., Lindsay E.K., Villalba D.K., Chin B. Mindfulness training and physical health: mechanisms and outcomes. Psychosom Med. 2019;81(3):224–232. doi: 10.1097/PSY.0000000000000675. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Cheung Y.S., Wen W.T.Z., Chundayil A.R., Phan P., Ci-En E.C. Impact of disease cyclicity on quality-of-life impairment—A mixed method explanatory study. JAAD Int. 2025;18:180–187. doi: 10.1016/j.jdin.2024.09.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Michie S., van Stralen M.M., West R. The behaviour change wheel: a new method for characterising and designing behaviour change interventions. Implement Sci. 2011;6(1):42. doi: 10.1186/1748-5908-6-42. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Macis M., Grunauer M., Gutierrez E., et al. Using incentives and nudging to improve non-targeted HIV testing in Ecuador: a randomized trial. AIDS Behav. 2021;25(8):2542–2550. doi: 10.1007/s10461-021-03215-x. [DOI] [PubMed] [Google Scholar]
- 41.Choi E., Mak W.K., Law J.Y., Santos D., Quek S.C. Optimizing teledermatology: looking beyond the COVID-19 pandemic. Int J Dermatol. 2021;60(1):119–121. doi: 10.1111/ijd.15272. [DOI] [PubMed] [Google Scholar]
- 42.Choi E.C.E., Heng L.W., Tan S.Y.L., Phan P.H.C., Chandran N.S. Factors influencing willingness to pay and show images with teledermatology during the COVID19 pandemic. J Am Acad Dermatol. 2022;87(1):e19–e21. doi: 10.1016/j.jaad.2022.02.053. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Choi E.C.E., Heng L.W., Tan S.Y., Phan P., Chandran N.S. Factors influencing use and perceptions of teledermatology: a mixed-methods study of 942 participants. JAAD Int. 2022;6:97–103. doi: 10.1016/j.jdin.2021.12.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Harkness E., Macdonald W., Valderas J., Coventry P., Gask L., Bower P. Identifying psychosocial interventions that improve both physical and mental health in patients with diabetes: a systematic review and meta-analysis. Diabetes Care. 2010;33(4):926–930. doi: 10.2337/dc09-1519. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Beard C., Stein A.T., Hearon B.A., Lee J., Hsu K.J., Björgvinsson T. Predictors of depression treatment response in an intensive CBT partial hospital. J Clin Psychol. 2016;72(4):297–310. doi: 10.1002/jclp.22269. [cited 2025 Aug 9] [DOI] [PubMed] [Google Scholar]
- 46.Wadsworth L.P., Forgeard M., Hsu K.J., Kertz S., Treadway M., Björgvinsson T. Examining the role of repetitive negative thinking in relations between positive and negative aspects of self-compassion and symptom improvement during intensive treatment. Cogn Ther Res. 2018;42(3):236–249. [Google Scholar]
- 47.Sumner J., Bundele A., Lim H.W., Phan P., Motani M., Mukhopadhyay A. Developing an artificial intelligence-driven nudge intervention to improve medication adherence: a human-centred design approach. J Med Syst. 2023;48(1):3. doi: 10.1007/s10916-023-02024-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Toh S.H.Y., Tan J.H.Y., Kosasih F.R., Sündermann O. Efficacy of the mental health app intellect to reduce stress: randomized controlled trial with a 1-Month Follow-up. JMIR Form Res. 2022;6(12) doi: 10.2196/40723. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Ong W.Y., Sündermann O. Efficacy of the mental health app “Intellect” to improve body image and self-compassion in young adults: a randomized controlled trial with a 4-Week Follow-up. JMIR MHealth UHealth. 2022;10(11) doi: 10.2196/41800. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Michie S., Richardson M., Johnston M., et al. The behavior change technique taxonomy (v1) of 93 hierarchically clustered techniques: building an international consensus for the reporting of behavior change interventions. Ann Behav Med Publ Soc Behav Med. 2013;46(1):81–95. doi: 10.1007/s12160-013-9486-6. [DOI] [PubMed] [Google Scholar]
- 51.Qin Y., Omar B., Musetti A. The addiction behavior of short-form video app TikTok: the information quality and system quality perspective. Front Psychol. 2022;13 doi: 10.3389/fpsyg.2022.932805. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Montag C., Yang H., Elhai J.D. On the psychology of TikTok use: a first glimpse from empirical findings. Front Public Health. 2021;9 doi: 10.3389/fpubh.2021.641673. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Tran S., Smith L., Carter S. Understanding patient perspectives on the use of gamification and incentives in mHealth apps to improve medication adherence: qualitative study. JMIR MHealth UHealth. 2024;12 doi: 10.2196/50851. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Rutledge C., Walsh C.M., Swinger N., et al. Quality Cardiopulmonary Resuscitation QCPR leaderboard investigators of the International Network for Simulation-based Pediatric Innovation, Research, and Education INSPIRE Gamification in action: theoretical and practical considerations for medical educators. Acad Med J Assoc Am Med Coll. 2018;93(7):1014–1020. doi: 10.1097/ACM.0000000000002183. [DOI] [PubMed] [Google Scholar]
- 55.Intellect redefining mental health for global workforces. [Internet]. [cited 2025 July 18]. Available from: https://intellect.co/
- 56.von Stülpnagel C.C., Augustin M., Düpmann L., da Silva N., Sommer R. Mapping risk factors for cumulative life course impairment in patients with chronic skin diseases - a systematic review. J Eur Acad Dermatol Venereol JEADV. 2021;35(11):2166–2184. doi: 10.1111/jdv.17348. [DOI] [PubMed] [Google Scholar]
- 57.Fritzson E., Salafia C., Bellizzi K.M., Park C.L. Cascading pathways from physical symptom burden to distress in adults with cancer. Health Psychol. 2025;44(1):57–65. doi: 10.1037/hea0001420. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Horan M.R., Srivastava D.K., Choi J., et al. Multilevel characteristics of cumulative symptom burden in young survivors of childhood cancer. JAMA Netw Open. 2024;7(5) doi: 10.1001/jamanetworkopen.2024.10145. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Choi E., Long V., Phan P., et al. Protocol for a double-blinded randomised controlled trial and process evaluation of a digital psychotherapeutic app in Singapore to improve symptom burden in patients with dermatological problems. BMJ Open. 2025;15(7) doi: 10.1136/bmjopen-2024-098266. [DOI] [PMC free article] [PubMed] [Google Scholar]


